The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Parenteral Anticoagulants
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,487
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404073301402 · Cited by 2,589
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328
(1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362401 · Cited by 1,883
ACC/AHA guidelines for the management of patients with acute myocardial infarction
Committee Members, Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,850
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Self-citationVTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Braunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D., Kupersmith, J., Levin, T. N., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00889-5 · Cited by 963
Hirsh, J., & Levine, M. (1992) · Blood · doi:10.1182/blood.v79.1.1.bloodjournal7911 · Cited by 894
A 14-year study of heparin-induced thrombocytopenia
Warkentin, T. E., & Kelton, J. G. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00258-6 · Cited by 886
Suppression by heparin of smooth muscle cell proliferation in injured arteries
CLOWES, A. W., & KARNOWSKY, M. J. (1977) · Nature · doi:10.1038/265625a0 · Cited by 790
Hirsh, J., Bauer, K. A., Donati, M. B., Gould, M., Samama, M. M., & Weitz, J. I. (2008) · Chest · doi:10.1378/chest.08-0689 · Cited by 755
Self-citationRaschke, R. A., Reilly, B. M., Guidry, J. R., Fontana, J. R., & Srinivas, S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00002 · Cited by 743
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Simoons, M. L. (1996) · RePub (Erasmus University Rotterdam) · Cited by 706
Basu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661
A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
(1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351103 · Cited by 660
Choay, J., Petitou, M., Lormeau, J. C., Sinaÿ, P., Casu, B., & Gatti, G. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)90550-8 · Cited by 647
Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.
Merlini, P. A., Bauer, K. A., Oltrona, L., Ardissino, D., Cattaneo, M., Belli, C., Mannucci, P. M., & Rosenberg, R. D. (1994) · Circulation · doi:10.1161/01.cir.90.1.61 · Cited by 597
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction
Ryan, T. J., Antman, E. M., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B., Russell, R. O., Smith, E. E., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00351-4 · Cited by 592
Effect of Heparin and Heparin Fractions on Platelet Aggregation
Salzman, E. W., Rosenberg, R. D., Smith, M. H., Lindon, J. N., & Favreau, L. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109661 · Cited by 591
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Heparin : chemical and biological properties, clinical applications
Lane, D. A., & Lindahl, U. (1989) · Edward Arnold eBooks · Cited by 533
THE THROMBOPLASTIC ACTION OF CEPHALIN
McLean, J. (1916) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1916.41.2.250 · Cited by 530
The separation of active and inactive forms of heparin
Lam, L. H., Silbert, J. E., & Rosenberg, R. D. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90558-1 · Cited by 492
Antman, E. M. (1996) · Circulation · doi:10.1161/01.cir.94.5.911 · Cited by 485
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W. (1990) · Biochemistry · doi:10.1021/bi00482a021 · Cited by 466
Andersson, L.-O., Barrowcliffe, T. W., Holmer, E., Johnson, E. A., & Sims, G. E. C. (1976) · Thrombosis Research · doi:10.1016/0049-3848(76)90105-5 · Cited by 457
Further characterization of the antithrombin-binding sequence in heparin
Thunberg, L., Bäckström, G., & Lindahl, U. (1982) · Carbohydrate Research · doi:10.1016/s0008-6215(00)81050-2 · Cited by 455
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
Lim, W., Dentali, F., Eikelboom, J. W., & Crowther, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-9-200605020-00011 · Cited by 443
van Dongen, C. J., van den Belt, A. G., Prins, M. H., & Lensing, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub2 · Cited by 433
Levine, M. N. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.49 · Cited by 403
Structure of the antithrombin-binding site in heparin.
Lindahl, U., Bäckström, G., Höök, M., Thunberg, L., Fransson, L. A., & Linker, A. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.7.3198 · Cited by 368
Swan, S. K., & Hursting, M. J. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.318.34881 · Cited by 368
Overweight, Obesity, and the Risk of Recurrent Venous Thromboembolism
Eichinger, S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1678 · Cited by 361
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
Lane, D. A., Denton, J., Flynn, A. M., Thunberg, L., & Lindahl, U. (1984) · Biochemical Journal · doi:10.1042/bj2180725 · Cited by 342
Extension and structural variability of the antithrombin-binding sequence in heparin.
Lindahl, U., Thunberg, L., Bäckström, G., Riesenfeld, J., Nordling, K., & Björk, I. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90755-6 · Cited by 340
Jordan, R. E., Oosta, G. M., Gardner, W. T., & Rosenberg, R. D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70431-1 · Cited by 333
Carter, C., Kelton, J., Hirsh, J., Cerskus, A., Santos, A., & Gent, M. (1982) · Blood · doi:10.1182/blood.v59.6.1239.1239 · Cited by 331
Establishing a Therapeutic Range for Heparin Therapy
Brill-Edwards, P., Ginsberg, J. S., Johnston, M., & Hirsh, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00002 · Cited by 329
Casu, B., Oreste, P., Torri, G., Zoppetti, G., Choay, J., Lormeau, J. C., Petitou, M., & Sinaɕ, P. (1981) · Biochemical Journal · doi:10.1042/bj1970599 · Cited by 326
Bijsterveld, N. R., Moons, A. H., Boekholdt, S. M., van Aken, B. E., Fennema, H., Peters, R. J. G., Meijers, J. C. M., Büller, H. R., & Levi, M. (2002) · Circulation · doi:10.1161/01.cir.0000038501.87442.02 · Cited by 316
Castellot, J. J., Favreau, L. V., Karnovsky, M. J., & Rosenberg, R. D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33750-5 · Cited by 310
Erkens, P. M., & Prins, M. H. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub3 · Cited by 301
Heparin-Induced Thrombocytopenia Associated with Fondaparinux
(2007) · New England Journal of Medicine · doi:10.1056/nejmc070346 · Cited by 283
Outbreak of Adverse Reactions Associated with Contaminated Heparin
Blossom, D. B., Kallen, A. J., Patel, P. R., Elward, A., Robinson, L., Gao, G., Langer, R., Perkins, K. M., Jaeger, J. L., Kurkjian, K. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806450 · Cited by 282
Correlation between structure and function of heparin
Rosenberg, R. D., & Lam, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1218 · Cited by 281
Heparin kinetics in venous thrombosis and pulmonary embolism.
Hirsh, J., van Aken, W. G., Gallus, A. S., Dollery, C. T., Cade, J. F., & Yung, W. L. (1976) · Circulation · doi:10.1161/01.cir.53.4.691 · Cited by 277
Pettilä, V., Leinonen, P., Markkola, A., Hiilesmaa, V., & Kaaja, R. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612970 · Cited by 275
Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis
Abildgaard, U. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365516809076981 · Cited by 275
Scholten, D. J., Hoedema, R. M., & Scholten, S. E. (2002) · Obesity Surgery · doi:10.1381/096089202321144522 · Cited by 274
Early Anticoagulation Is Associated With Reduced Mortality for Acute Pulmonary Embolism
Smith, S. B., Geske, J. B., Maguire, J. M., Zane, N. A., Carter, R. E., & Morgenthaler, T. I. (2010) · Chest · doi:10.1378/chest.09-0959 · Cited by 267
A standard heparin nomogram for the management of heparin therapy
Cruickshank, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.2.333 · Cited by 266
Landefeld, C. S., Cook, E. F., Flatley, M., Weisberg, M., & Goldman, L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90004-0 · Cited by 264
Structure of the hirugen and hirulog 1 complexes of α-thrombin
Skrzypczak-Jankun, E. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80132-e · Cited by 261
Kearon, C., Ginsberg, J. S., Julian, J. A., Douketis, J., Solymoss, S., Ockelford, P., Jackson, S., Turpie, A. G., MacKinnon, B., Hirsh, J., et al. (2006) · JAMA · doi:10.1001/jama.296.8.935 · Cited by 259
Kinetics of intravenously administered heparin in normal humans
de Swart, C., Nijmeyer, B., Roelofs, J., & Sixma, J. (1982) · Blood · doi:10.1182/blood.v60.6.1251.1251 · Cited by 253
Laposata, M., Green, D., Cott, E. M. V., Barrowcliffe, T. W., Goodnight, S. H., & Sosolik, R. C. (1998) · PubMed · Cited by 249
Olson, J. D., Arkin, C. F., Brandt, J. T., Cunningham, M. T., Giles, A., Koepke, J. A., & Witte, D. L. (1998) · PubMed · Cited by 241
Rate vs Rhythm Control in Patients With Atrial Fibrillation: A Meta-analysis
de Denus, S. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.258 · Cited by 239
Holmer, E., Kurachi, K., & Söderström, G. (1981) · Biochemical Journal · doi:10.1042/bj1930395 · Cited by 239
A Standard Heparin Nomogram for the Management of Heparin Therapy
Cruickshank, M. K. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400020085018 · Cited by 237
Brinkhous, K. M., Smith, H. P., Warner, E. D., & Seegers, W. H. (1939) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1939.125.4.683 · Cited by 234
The Mode of Action of Heparin in Plasma
Béguin, S., Lindhout, T., & Hemker, H. C. (1988) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646990 · Cited by 230
Nieuwenhuis, H., Albada, J., Banga, J., & Sixma, J. (1991) · Blood · doi:10.1182/blood.v78.9.2337.2337 · Cited by 226
STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN
Choay, J., Lormeau, J., Petitou, M., Sinay, P., & Fareed, J. (1981) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1981.tb29770.x · Cited by 224
Powers, P. J. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390040013003 · Cited by 214
Savi, P., Chong, B. H., Greinacher, A., Gruel, Y., Kelton, J. G., Warkentin, T. E., Eichler, P., Meuleman, D., Petitou, M., Herault, J.-P., et al. (2005) · Blood · doi:10.1182/blood-2004-05-2010 · Cited by 212
A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses
Crowther, M. A., Ginsberg, J. B., Kearon, C., Harrison, L., Johnson, J., Massicotte, M. P., & Hirsh, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.46 · Cited by 199
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
Sobel, M., McNeill, P. M., Carlson, P. L., Kermode, J. C., Adelman, B., Conroy, R., & Marques, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115198 · Cited by 197
Binding and endocytosis of heparin by human endothelial cells in culture
Bârzu, T., Molho, P., Tobelem, G., Petitou, M., & Caen, J. (1985) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(85)90177-6 · Cited by 192
Multiple functional domains of the heparin molecule.
Oosta, G. M., Gardner, W. T., Beeler, D. L., & Rosenberg, R. D. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.829 · Cited by 187
Minor Transplacental Passage of Fondaparinux in Vivo
Dempfle, C.-E. H. (2004) · New England Journal of Medicine · doi:10.1056/nejm200404293501825 · Cited by 187
The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers
Sanderink, G., Le Liboux, A., Jariwala, N., Harding, N., Ozoux, M., Shukla, U., Montay, G., Boutouyrie, B., & Miro, A. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127114 · Cited by 186
Handeland, G. F., Abildgaard, U., Holm, H. A., & Arnesen, K. E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280041 · Cited by 181
Francis, C. W., Pellegrini, V. D., Totterman, S., Boyd, A. D., Marder, V. J., Liebert, K. M., Stulberg, B. N., Ayers, D. C., Rosenberg, A., Kessler, C., et al. (1997) · The Journal of Bone and Joint Surgery (American Volume) · doi:10.2106/00004623-199709000-00011 · Cited by 171
Muir, J. M., Hirsh, J., Weitz, J. I., Andrew, M., Young, E., & Shaughnessy, S. G. (1997) · Blood · doi:10.1182/blood.v89.9.3236 · Cited by 171
Self-citationFrydman, A. M., Bara, L., Roux, Y. H., Woler, M., Chauliac, F., & Samama, M. M. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03184.x · Cited by 166
Self-citationBecker, R. C., Spencer, F. A., Gibson, M., Rush, J. E., Sanderink, G., Murphy, S. A., Ball, S. P., & Antman, E. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120774 · Cited by 166
Douketis, J. D., Cook, D., Meade, M., Guyatt, G., Geerts, W., Skrobik, Y., Albert, M., Granton, J., Hébert, P., Pagliarello, G., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.16.1805 · Cited by 155
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
Shaughnessy, S., Young, E., Deschamps, P., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1368.bloodjournal8641368 · Cited by 152
The Elimination from Plasma of Intravenous Heparin An Experimental Study on Dogs and Humans
Olsson, P., Lagergren, H., & Ek, S. (1963) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1963.tb17446.x · Cited by 147
Bleeding associated with antithrombotic therapy.
Jg, K., & Hirsh, J. (1980) · PubMed · Cited by 147
Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect
Fernandez, F., Nguyên, P., van Ryn, J., Ofosu, F. A., Hirsh, J., & Buchanan, M. R. (1986) · Thrombosis Research · doi:10.1016/0049-3848(86)90094-0 · Cited by 139
Four Heparin Preparations: Anti-Xa Potentiating Effect of Heparin after Subcutaneous Injection
Johnson, E. A., Kirkwood, T. B. L., Stirling, Y., et al. (1976) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648001 · Cited by 137
Atha, D. H., Lormeau, J. C., Petitou, M., ROSENBERG, R. D., & Choay, J. (1987) · Biochemistry · doi:10.1021/bi00394a024 · Cited by 136
Heparin kinetics determined by three assay methods
Bjornsson, T. D., Wolfram, K. M., & Kitchell, B. B. (1982) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1982.16 · Cited by 136
Nesheim, M. E. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43920-2 · Cited by 131
Aghassarian, M., Drouet, L. O., Sollier, C. B. D., Lacut, K., Heilmann, J., Mottier, D., Bergmann, J., & Mahé, I. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-09-0513 · Cited by 129
Kalfarentzos, F. E., Yarmenitis, S. D., Kehagias, I., Karamesini, M., Dimitrakopoulos, A., Maniati, A., & Stavropoulou, F. (2001) · Obesity Surgery · doi:10.1381/09608920160558588 · Cited by 128
Customize your JAMA Network experience by selecting one or more topics from the list below. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.10.1077 · Cited by 127
Vascular sequestration of heparin
Mahadoo, J., Hiebert, L. M., & Jaques, L. B. (1978) · Thrombosis Research · doi:10.1016/0049-3848(78)90087-7 · Cited by 126
Ofosu, F. A., Siè, P., Modi, G. J., Fernandez, F., Buchanan, M. R., Blajchman, M. A., Boneu, B., & Hirsh, J. (1987) · Biochemical Journal · doi:10.1042/bj2430579 · Cited by 123
Massonnet-Castel, S., Pélissier, E., Bara, L., Terrier, E., Abry, B., Guibourt, P., Swanson, J., Jaulmes, B., Carpentier, A., & Samama, M. M. (2009) · Haemostasis · doi:10.1159/000215283 · Cited by 122
Self-citationThe Effectiveness of Implementing the Weight-Based Heparin Nomogram as a Practice Guideline
Raschke, R. A., Gollihare, B., & Peirce, J. C. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440140067006 · Cited by 120
Impairment by Heparin of Primary Haemostasis and Platelet [14C]5‐Hydroxytryptamine Release
Heiden, D., Mielke, C. H., & Rodvien, R. (1977) · British Journal of Haematology · doi:10.1111/j.1365-2141.1977.tb00666.x · Cited by 117
Hirsh, J., & Weitz, J. I. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09233-2 · Cited by 114
Self-citationCatabolism of low-dose heparin in man
Dawes, J., & Pepper, D. S. (1979) · Thrombosis Research · doi:10.1016/0049-3848(79)90004-5 · Cited by 113
Iampietro, R., Woolley, A. M., Preston, F. E., & Kitchen, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614377 · Cited by 112
Blajchman, M. A., Young, E., & Ofosu, F. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22507.x · Cited by 105
Vergnes, C., Brun, J.-L., Paolucci, F., Nadal, T., Leng, J. J., Saux, M., Banwarth, B., & Lagrange, F. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613092 · Cited by 103
Simone, E. P., Madan, A. K., Tichansky, D. S., Kuhl, D. A., & Lee, M. D. (2008) · Surgical Endoscopy · doi:10.1007/s00464-008-9997-6 · Cited by 99
Weitz, J. I. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63664-4 · Cited by 98
Self-citationWawrzyńska, L., Tomkowski, W. Z., Przedlacki, J., Hajduk, B., & Torbicki, A. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073848 · Cited by 96
Wilson, J.-A. S., Wilbur, K., Burton, E., & Anderson, D. R. (2001) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000048043 · Cited by 95
Shojania, A. M., Tetreault, J., & Turnbull, G. J. (1988) · American Journal of Clinical Pathology · doi:10.1093/ajcp/89.1.19 · Cited by 89
Carlson, M. K., Gleason, P. P., & Sen, S. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.1.108.34436 · Cited by 88
Landefeld, C. S., McGuire, E. J., & Rosenblatt, M. W. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90174-c · Cited by 86
Bates, S. M., Weitz, J. I., Johnston, M., Hirsh, J., & Ginsberg, J. S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.385 · Cited by 84
Self-citationContemporary Laboratory Monitoring of Low Molecular Weight Heparins
Samama, M. M., & Poller, L. (1995) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30347-0 · Cited by 83
Self-citationIntravenous nitroglycerin-induced heparin resistance: A qualitative antithrombin III abnormality
Becker, R. C., Corrao, J. M., Bovill, E. G., Gore, J. M., Baker, S. P., Miller, M. L., Lucas, F. V., & Alpert, J. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80172-3 · Cited by 82
Pini, M., Pattacini, C., Quintavalla, R., Poli, T., Megha, A., Tagliaferri, A., Manotti, C., & Dettori, A. G. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647289 · Cited by 82
Li, B., Suwan, J., Martin, J. G., Zhang, F., Zhang, Z., Hoppensteadt, D., Clark, M., Fareed, J., & Linhardt, R. J. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.012 · Cited by 78
Stroke Prevention in Nonvalvular Atrial Fibrillation
Albers, G. W., Atwood, J. E., Hirsh, J., Sherman, D. G., Hughes, R. A., & Connolly, S. J. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-727 · Cited by 78
Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency
Rabbat, C. G., Cook, D. J., Crowther, M. A., McDonald, E., Clarke, F. J., Meade, M., Lee, K., & Cook, R. J. (2005) · Journal of Critical Care · doi:10.1016/j.jcrc.2005.09.009 · Cited by 75
HEPARIN DOSES AND MAJOR BLEEDINGS
Morabia, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91421-2 · Cited by 74
Lefkou, E. E., Khamashta, M. A., Hampson, G., & Hunt, B. J. (2009) · Lupus · doi:10.1177/0961203309353171 · Cited by 73
Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin
Eika, C. (1971) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1971.tb01976.x · Cited by 67
Parody, R., Oliver, A., Souto, J. C., & Fontcuberta, J. (2003) · PubMed · Cited by 66
Fondaparinux: A potential new therapy for HIT
Kuo, K. H. M., & Kovacs, M. J. (2005) · Hematology · doi:10.1080/10245330500093492 · Cited by 63
Ng, H. J. H., Koh, L. P., & Lee, L. H. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0633-1 · Cited by 61
Casele, H. L., & Laifer, S. A. (2000) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(200003/04)9:2<122::aid-mfm7>3.0.co;2-q · Cited by 60
Friedman, Y., & Arsenis, C. (1974) · Biochemical Journal · doi:10.1042/bj1390699 · Cited by 55
Weitz, J. I., & Hirsh, J. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.715s · Cited by 51
Self-citationRacanelli, A., Fareed, J., Walenga, J. M., & Coyne, E. (1985) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1004373 · Cited by 47
Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey Continues
Blackmer, A. B., Oertel, M. D., & Valgus, J. M. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m136 · Cited by 44
In Vitro Reversal of Heparin Effect with Heparinas
Despotis, G. J., Summerfield, A. L., Joist, J. H., et al. (1994) · Anesthesia & Analgesia · doi:10.1213/00000539-199410000-00009 · Cited by 42
Heparin Metabolism: Isolation and Characterization of Uroheparin
McAllister, B. M., & Demis, D. J. (1966) · Nature · doi:10.1038/212293a0 · Cited by 40
Incomplete Reversal of Enoxaparin-Induced Bleeding by Protamine Sulfate
Bang, C. J., Berstad, A., & Talstad, I. (2009) · Haemostasis · doi:10.1159/000216220 · Cited by 32
Imberti, D., Legnani, C., Baldini, E., Cini, M., Nicolini, A., Guerra, M., Paoli, M. D., Zanardi, A., & Palareti, G. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.04.021 · Cited by 29
Anti-Xa activity in obese patients after double standard dose of nadroparin for prophylaxis
Heizmann, M., Baerlocher, G. M., Steinmann, F., Horber, F., & Wuillemin, W. A. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00188-3 · Cited by 28
Manzato, F., Mengoni, A., Grilenzoni, A., & Lippi, G. (1998) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1998.168 · Cited by 27
Comparing Different Lots of Activated Partial Thromboplastin Time Reagent: Analysis of Two Methods
Rosborough, T. K. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/110.2.173 · Cited by 27
Heparin Synergistically Enhances Interleukin-11 Signaling through Up-regulation of the MAPK Pathway
Rajgopal, R., Butcher, M. K., Weitz, J. I., & Shaughnessy, S. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600169200 · Cited by 21
Self-citationManagement of Iliofemoral Thrombosis in a Pregnant Patient With Heparin Resistance
Anand, S. S. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440280157015 · Cited by 15
A novel protamine variant reversal of heparin anticoagulation in human blood in vitro
Hulin, M. S., Wakefield, T. W., Andrews, P., Wrobleski, S. K., Stoneham, M. D., Doyle, A. R., Zelenock, G. B., Jacobs, L. A., Shanley, C. J., TenCate, V. M., et al. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70018-1 · Cited by 13
Antiphospholipid antibodies and ischemic stroke.
Brey, R. L. (1992) · PubMed · Cited by 7
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.017 · Cited by 3,595
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Metadata
- Authors
- Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 141
- Issue
- 2
- Pages
- e24S-e43S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2054730686
- Cited by
- 1,091
- References
- 140
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.